David James Lennon - 01 Mar 2025 Form 4 Insider Report for Aadi Bioscience, Inc. (WHWK)

Role: CHIEF EXECUTIVE OFFICER, Director
Signature: /s/ Stephen Rodin, as Attorney-in-Fact
Issuer symbol: WHWK
Transactions as of: 01 Mar 2025
Net transactions value: -$13,372
Form type: 4
Filing time: 03 Mar 2025, 20:37:50 UTC
Previous filing: 03 Oct 2024
Next filing: 03 Apr 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AADI	Common Stock	Options Exercise		+16,250	+71%		39,119	01 Mar 2025	Direct	F1
transaction	AADI	Common Stock	Sale	$13,372	-5,690	-15%	$2.35	33,429	03 Mar 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AADI	Restricted Stock Units	Options Exercise	$0	-16,250	-25%	$0.000000	48,750	01 Mar 2025	Common Stock	16,250		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock.
F2	Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
F3	Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024.